The clinical challenge published in the April issue of Inside Patient Care: Pharmacy & Clinics was an interesting case study. Gender identity has been receiving a lot of media coverage recently; a great deal of the coverage surrounds legal issues specific to gender-neutral amenities for transgender people.
I thank Dr Drummond for his comments on the clinical challenge we published last month. With the legal and healthcare issues impacting the transgender community, providers need to have a heightened awareness of the transgender community to address their very specific and growing needs. Retail pharmacies and the clinics within their walls strive to provide the best customer service to all customers and should do so in a personalized manner.
The state of Massachusetts has recently introduced a bill seeking to recognize pharmacists as healthcare providers.
As healthcare professionals, our attire can impact our patients’ well-being, protect our personal comfort and safety, and reduce the risk of spreading infectious pathogens.
  • Potassium May Lower Blood Pressure In Teens
  • Healthcare Spending On The Rise For Children With Diabetes
  • Oropharyngeal Exercises Help Snoring
  • Outbreak of Hiv In Indiana Linked to Oxymorphone Injection
  • 5 Facts About HB 2041
Misoprostol is a synthetic prostaglandin E1 analogue that has labeled uses for the prevention of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers and the medical termination of pregnancies.
Adequate calcium consumption and weight-bearing physical activity build strong bones, optimize bone mass, and may reduce the risk for osteoporosis later in life. The following are tips to maintain bone health for women:
Approximately 2 million to 4 million people in the United States, and 3% of the world’s population, are thought to be infected with the hepatitis C virus (HCV).
The FDA has announced that it will require prescription testosterone product labels to include a warning about a possible increased risk of heart attacks and strokes in patients using the medication, as well as require manufacturers of these products to change the labeling so that approved uses of the medications are clear. The agency is also encouraging healthcare professionals to prescribe testosterone therapy only for men whose low testosterone levels are caused by certain medical conditions and confirmed with appropriate laboratory testing.
A new payment model announced by the US Department of Health & Human Services offers providers the potential to receive at least $160 per month for patients who are undergoing chemotherapy treatment. The per-beneficiary, per-month (PBPM) allocation is part of a 2-pronged approach that also includes a performance-based payment to incentivize practices to reduce costs and improve care for this patient population. Hormonal therapies, including antiandrogen therapy used for the treatment of prostate cancer, are among the therapeutic regimens eligible for inclusion under this model.
Page 1 of 2
Results 1 - 10 of 16
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist